Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
oxidative stress3585 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26423 | 20485142 | Ann Surg | Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content. | 2010 | Details |
A26428 | 20473151 | Curr Opin Clin Nutr Metab Care | Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation. | 2010 | Details |
A26430 | 20471811 | Exp Toxicol Pathol | Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis. | 2010 | Details |
A26438 | 20460920 | Dig Dis | Genetic and environmental susceptibility to non-alcoholic fatty liver disease. | 2010 | Details |
A26441 | 20460917 | Dig Dis | Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. | 2010 | Details |
A26449 | 20460909 | Dig Dis | Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. | 2010 | Details |
A26469 | 20432253 | Hepatology | Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. | 2010 | Details |
A26478 | 20415685 | Diabetes Obes Metab | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 | Details |
A26486 | 20406065 | Biomark Med | Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? | 2010 | Details |
A26487 | 20403043 | Pathol Int | Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: Comparison with telomere-specific quantitative FISH and p21 immunohistochemistry. | 2010 | Details |
A26493 | 20398645 | Clin Biochem | Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. | 2010 | Details |
A26497 | 20392616 | Nutr Metab Cardiovasc Dis | Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26502 | 20388084 | Curr Pharm Des | Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. | 2010 | Details |
A26514 | 20370930 | J Med Case Rep | Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series. | 2010 | Details |
A26516 | 20370678 | Curr Pharm Des | Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. | 2010 | Details |
A26525 | 20368739 | Nat Rev Gastroenterol Hepatol | The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. | 2010 | Details |
A26533 | 20347174 | J Hepatol | Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. | 2010 | Details |
A26540 | 20300479 | Mediators Inflamm | Inflammatory mediators of hepatic steatosis. | 2010 | Details |
A26553 | 20216561 | Eur J Clin Nutr | Dietary and physical activity patterns in children with fatty liver. | 2010 | Details |
A26571 | 20189787 | Prostaglandins Leukot Essent Fatty Acids | Fatty liver: role of inflammation and fatty acid nutrition. | 2010 | Details |
A26572 | 20188144 | Biochim Biophys Acta | Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. | 2010 | Details |
A26582 | 20168226 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2010 | Details |
A26593 | 20138495 | J Nutr Biochem | Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. | 2010 | Details |
A26598 | 20119733 | Obes Surg | Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. | 2010 | Details |
A26608 | 20101463 | Dig Dis Sci | Nonalcoholic fatty liver disease: a review and update. | 2010 | Details |
A26644 | 22308119 | Hepat Mon | N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease. | 2010 | Details |
A26656 | 20038265 | Immunopharmacol Immunotoxicol | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. | 2010 | Details |
A26660 | 20032580 | J Atheroscler Thromb | Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. | 2009 | Details |
A26666 | 20025483 | Pathology | Olive leaf extract prevents spontaneous occurrence of non-alcoholic steatohepatitis in SHR/NDmcr-cp rats. | 2010 | Details |
A26679 | 19961393 | Clin Chem Lab Med | Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. | 2010 | Details |
A26688 | 19948621 | Pediatrics | Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. | 2009 | Details |
A26691 | 19946731 | J Gastroenterol | Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. | 2009 | Details |
A26700 | 19934372 | Exp Biol Med (Maywood) | Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors. | 2009 | Details |
A26713 | 19914374 | Free Radic Biol Med | Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. | 2009 | Details |
A26725 | 19891587 | Scand J Gastroenterol | Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis. | 2009 | Details |
A26737 | 19875987 | Obesity (Silver Spring) | Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. | 2009 | Details |
A26738 | 21160968 | World J Hepatol | Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. | 2009 | Details |
A26741 | 19860210 | Rinsho Byori | [Diagnosis and therapy in NASH]. | 2009 | Details |
A26743 | 19851063 | Ann Nutr Metab | Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection. | 2009 | Details |
A26745 | 19847649 | Dig Dis Sci | The effects of a fat- and sugar-enriched diet and chronic stress on nonalcoholic fatty liver disease in male Wistar rats. | 2009 | Details |
A26746 | 19845871 | Obes Rev | Non-alcoholic fatty liver disease from pathogenesis to management: an update. | 2009 | Details |
A26773 | 19816994 | Hepatology | Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. | 2009 | Details |
A26793 | 19777393 | Curr Opin Investig Drugs | Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. | 2009 | Details |
A26801 | 19756959 | Mol Cell Biochem | Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis. | 2009 | Details |
A26812 | 19733470 | J Nutr Biochem | Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. | 2009 | Details |
A26820 | 19724016 | Am J Physiol Endocrinol Metab | Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. | 2009 | Details |
A26825 | 19702912 | J Gastroenterol Hepatol | Effect of dietary fat to produce non-alcoholic fatty liver in the rat. | 2009 | Details |
A26857 | 19637730 | Rev Invest Clin | [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview]. | 2009 | Details |
A26870 | 19609863 | Histol Histopathol | Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
A26886 | 19584965 | Drugs Today (Barc) | Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders? | 2009 | Details |
A26902 | 19562447 | Surg Today | Effects of N-acetylcysteine on regeneration following partial hepatectomy in rats with nonalcoholic fatty liver disease. | 2009 | Details |
A26946 | 19490416 | Liver Int | Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. | 2009 | Details |
A26953 | 19473430 | Hepatol Res | The effect of ursodeoxycholic acid on liver regeneration after partial hepatectomy in rats with non-alcoholic fatty liver disease. | 2009 | Details |
A26958 | 19464748 | J Hepatol | 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. | 2009 | Details |
A26968 | 19444865 | Diabetes Metab Res Rev | Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. | 2009 | Details |
A26975 | 19427351 | Toxicology | Protective effect of bicyclol on tetracycline-induced fatty liver in mice. | 2009 | Details |
A26989 | 19396962 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2009 | Details |
A26990 | 19393338 | Biochim Biophys Acta | Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells. | 2009 | Details |
A26993 | 19386026 | Liver Int | Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. | 2009 | Details |
A27000 | 19370776 | World J Gastroenterol | Olive oil consumption and non-alcoholic fatty liver disease. | 2009 | Details |
A27005 | 19363256 | J Alzheimers Dis | Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. | 2009 | Details |
A27011 | 19359149 | Nutr Metab Cardiovasc Dis | Hepatic lipid metabolism and non-alcoholic fatty liver disease. | 2009 | Details |
A27013 | 19355912 | Curr Mol Med | Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. | 2009 | Details |
A27015 | 19352614 | J Mol Med (Berl) | Molecular mechanisms involved in NAFLD progression. | 2009 | Details |
A27027 | 19321579 | J Nutr | Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. | 2009 | Details |
A27042 | 19285022 | Biochem Biophys Res Commun | The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. | 2009 | Details |
A27044 | 19282820 | Obesity (Silver Spring) | Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. | 2009 | Details |
A27060 | 19243311 | Clin Sci (Lond) | Metabolic disturbances in non-alcoholic fatty liver disease. | 2009 | Details |
A27062 | 19240815 | Hippokratia | Non alcoholic fatty liver disease and metabolic syndrome. | 2009 | Details |
A27072 | 19223251 | Dig Liver Dis | Non-alcoholic fatty liver disease pathogenesis: the present and the future. | 2009 | Details |
A27106 | 19165171 | Obesity (Silver Spring) | Liver NF-kappaB and AP-1 DNA binding in obese patients. | 2009 | Details |
A27114 | 19147984 | J Clin Invest | Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. | 2009 | Details |
A27115 | 19144866 | Exp Biol Med (Maywood) | Fatty acid composition and development of hepatic lipidosis during food deprivation--mustelids as a potential animal model for liver steatosis. | 2009 | Details |
A27154 | 19073452 | Orv Hetil | [Silymarin in the treatment of chronic liver diseases: past and future]. | 2008 | Details |
A27157 | 19072356 | Expert Rev Gastroenterol Hepatol | Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C. | 2008 | Details |
A27163 | 19065650 | Hepatology | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. | 2009 | Details |
A27165 | 19056644 | J Nutr | Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. | 2008 | Details |
A27168 | 19054139 | Hepatol Res | Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. | 2008 | Details |
A27183 | 19025308 | Rev Esp Enferm Dig | [Molecular basis of obesity-related hepatic steatosis]. | 2008 | Details |
A27192 | 19013572 | Atherosclerosis | Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. | 2008 | Details |
A27216 | 18956298 | Semin Liver Dis | Effects of weight loss on nonalcoholic fatty liver disease. | 2008 | Details |
A27219 | 18956295 | Semin Liver Dis | Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. | 2008 | Details |
A27222 | 18956292 | Semin Liver Dis | Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. | 2008 | Details |
A27223 | 18956291 | Semin Liver Dis | Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. | 2008 | Details |
A27231 | 18942340 | Pol Merkur Lekarski | [Non invasive markers of non-alcoholic steatohepatitis]. | 2008 | Details |
A27233 | 18939388 | Cleve Clin J Med | Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. | 2008 | Details |
A27234 | 18938777 | Scand J Gastroenterol | Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet. | 2008 | Details |
A27235 | 18936912 | Naunyn Schmiedebergs Arch Pharmacol | A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia. | 2008 | Details |
A27255 | 18824034 | Prog Lipid Res | Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). | 2008 | Details |
A27258 | 18822121 | BMC Mol Biol | Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet. | 2008 | Details |
A27265 | 18804555 | Contemp Clin Trials | Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. | 2008 | Details |
A27273 | 18782455 | BMC Gastroenterol | Resveratrol inhibits nonalcoholic fatty liver disease in rats. | 2008 | Details |
A27277 | 18769764 | Biol Res | Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease. | 2008 | Details |
A27281 | 18760271 | Clin Chim Acta | A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease. | 2008 | Details |
A27282 | 18753993 | Ann Hepatol | Leptin in nonalcoholic fatty liver disease. | 2009 | Details |
A27286 | 18752470 | Biochem J | High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. | 2009 | Details |
A27298 | 18702346 | Pol Merkur Lekarski | [Non-alcoholic fatty liver disease--new view]. | 2008 | Details |
A27299 | 18698683 | World J Gastroenterol | Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis. | 2008 | Details |
A27310 | 18672640 | J Med Assoc Thai | Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease. | 2008 | Details |
A27346 | 18609067 | Scand J Clin Lab Invest | Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. | 2008 | Details |